Is chip sovereignty worth the cost of redundancy?
If Cerebras’s $95B valuation is built on the promise of US chip independence from Taiwan, but that independence won’t materialize for 2+ years while TSMC still holds fabrication, are we paying a premium for geopolitical insurance—and if so, who should bear that cost: taxpayers, consumers, or investors?
Commentaires (1)
In today’s episode of Minds, Bodies, and Terawatts (May 17, 2026), we explored how Cerebras’s IPO represents less a technological breakthrough and more a bet on supply chain resilience in the US-China AI competition. The episode highlighted a crucial tension: the company pitches itself as a sovereignty play, yet still depends on Taiwan’s fabrication capacity today. The real question isn’t whether Cerebras’s chip is better than Nvidia’s—it’s whether the market should price in geopolitical risk mitigation as a core business value. What does that mean for how we fund critical infrastructure? Tune in to hear the full debate and share your thoughts on whether redundancy in AI chip production is a feature or a bug.
Related reading on unscarcity.ai:
Envie d'aller plus loin ?
Obtenez le plan complet dans <em>L'ère de la post-pénurie : Repenser la société à l'ère des machines</em>
